Media ReleasesSomnomed Limited

View All Somnomed Limited News


SomnoMed, Investor Presentation - Financial Year 2016/17

GLOBAL HIGHLIGHTS 2016/17 - A TRANSITIONAL YEAR

Renew Sleep Solutions (“RSS”) – Seven centres opened in 2016/17

• Head office organisation, reimbursement and claims capabilities fully established

• Seven centres opened across six states in the US in the first year of trading and well ahead of plan

• Centre investment and start-up cost below model assumptions

• Patient flow volumes tracking to plan

• Centre operating costs and head office expenses in line with expectations

• Breakeven reached in centres open for 5 months or longer

SomnoMed Core – Continued strong performance in Europe and US returning to growth

• Global MAS sales volumes +15.5%; group revenues +12%
- Good return to positive growth in US in fourth quarter
- Consistently strong sales performance and growth in Europe
- APAC flat due to lack of reimbursement and slow adoption of COATTM

• MAS gross margin improved from 68.6% to 70%, with group gross margin up to 58.4%

• EBITDA up 60% to $2.366m (excluding RSS)


To view Presentation please download PDF attached:
Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?